Treatment of colorectal liver metastases with a combination of RFA and chemotherapy strongly improves survival


The standard treatment for patients with colorectal cancer and unresectable metastases in their liver is chemotherapy. An international team of surgeons, supervised by prof. dr. Theo Ruers of the Netherlands Cancer Institute, has now shown that these patients are better off with a combination of chemotherapy and RFA (locally 'burning' the metastases). The 8-year survival rate in patients who received this combination was 36 percent, compared to just 9 percent in patients who only received chemotherapy.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.